Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sporadic Amyotrophic Lateral Sclerosis”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)UnknownNCT04744532
What this trial is testing

IPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Kyoto University 49
Testing effectiveness (Phase 2)Study completedNCT03204500
What this trial is testing

Dual Treatment With Lithium and Valproate in ALS.

Who this might be right for
Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis, Sporadic
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 43
Testing effectiveness (Phase 2)Study completedNCT02781454
What this trial is testing

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis

Who this might be right for
Sporadic Amyotrophic Lateral Sclerosis
University of Washington 20
Early research (Phase 1)Looking for participantsNCT07100119
What this trial is testing

LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Eli Lilly and Company 32
Not applicableLooking for participantsNCT05928416
What this trial is testing

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

Who this might be right for
Amyotrophic Lateral Sclerosis, SporadicAmyotrophic Lateral Sclerosis
ZIWIG 600
Not applicableWithdrawnNCT01459302
What this trial is testing

Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaPLS+7 more
University of Massachusetts, Worcester
Not applicableStudy completedNCT00015444
What this trial is testing

Screening and Natural History: Primary Lateral Sclerosis and Related Disorders

Who this might be right for
Primary Lateral Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 189
Early research (Phase 1)Ended earlyNCT06215755
What this trial is testing

VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Verge Genomics 54
Not applicableTemporarily pausedNCT03449212
What this trial is testing

SOD1 Kinetics Measurements in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis, FamilialAmyotrophic Lateral Sclerosis, Sporadic
Washington University School of Medicine 86
Not applicableStudy completedNCT05852405
What this trial is testing

Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Ambulanzpartner Soziotechnologie APST GmbH 2,000
Testing effectiveness (Phase 2)Study completedNCT01849770
What this trial is testing

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)

Who this might be right for
Sporadic Amyotrophic Lateral Sclerosis
University of Washington 75
Not applicableStudy completedNCT00821132
What this trial is testing

Genetics of Familial and Sporadic ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Familial Amyotrophic Lateral SclerosisALS With Frontotemporal Dementia (ALS/FTD)+4 more
Northwestern University 13,521
Early research (Phase 1)Looking for participantsNCT06665165
What this trial is testing

AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS
Amylyx Pharmaceuticals Inc. 48
Testing effectiveness (Phase 2)Study completedNCT05039099
What this trial is testing

Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
AL-S Pharma 73
Very early researchUnknownNCT02969759
What this trial is testing

Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis

Who this might be right for
Sporadic Amyotrophic Lateral Sclerosis
University Hospital, Angers 30
Not applicableStudy completedNCT02686268
What this trial is testing

Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS

Who this might be right for
C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
Washington University School of Medicine 128
Testing effectiveness (Phase 2)Study completedNCT03019419
What this trial is testing

Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS
Tokyo Medical University 66
Post-approval studies (Phase 4)Looking for participantsNCT05923905
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

Who this might be right for
Sporadic and Familial Amyotrophic Lateral Sclerosis
Peking University Third Hospital 64
Early research (Phase 1)UnknownNCT03981536
What this trial is testing

Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
AL-S Pharma 18